ArticleWorld journal of clinical oncology2025

Combining anti-PD-1 antibodies with surufatinib for gastrointestinal neuroendocrine carcinoma: Two cases report and review of literature.

Lou-Lu Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.